Is there peer-reviewer bias against research from low-income countries?

According to a paper from Harris et al. (2017), the country from which a study takes place greatly influences the academic community’s perception of that study.  The authors used a unique study design approach: In our randomized, controlled, and blinded crossover experiment, participants rated the same abstracts on two separate occasions, one month apart, with the…

IVI releases its Open-Source Value Project

The Innovation and Value Initiative (IVI)–where I serve as the Director of Research–today released its first Open-Source Value Project in rheumatoid arthritis.  I have pasted the press release below.  Go check it out! Press release:  The Innovation and Value Initiative (IVI) – a collaboration of academics, patient advocacy organizations, payers, life sciences companies, providers, delivery systems, and other organizations dedicated to finding scientifically…

IVI Model highlights ACR Conference

As reported in a Academy of Managed Care & Specialty Pharmacy newsletter, titled “Mathematical Model Aims to Improve Cost-Effectiveness of Rheumatology Treatment“, the Innovation and Value Initiative’s is highlighted from the American College of Rheumatology conference.  Here is an excerpt: Biological therapies for moderate to severe rheumatoid arthritis have significantly improved treatment and prognosis. However,…